Sanixtra CZ, s.r.o.
- Address
- Šiklové 3385/4, 150 00 Prague, Czechia
Allergy and Eye-Related Research
At Sanixtra CZ, s.r.o. in Prague, clinical research includes studies in Diseases of Environmental Origin and Eye Diseases, with a focus on allergic rhinoconjunctivitis linked to grass pollen exposure. These trials are designed to assess new treatment approaches and improve symptom control for people affected by seasonal allergies.
- Evaluating a new therapy for allergic rhinoconjunctivitis
- Improving relief for pollen-related eye and nasal symptoms
- Exploring treatment effectiveness in patients with or without asthma
The research aims to support better care for allergy sufferers by testing whether a more targeted approach can provide stronger and more reliable symptom improvement.
Cardiovascular Disease and Hypertension Studies
The site also conducts research in Cardiovascular Diseases, including hypertension, established cardiovascular disease, and high cardiovascular risk. These studies are focused on understanding whether new treatment options can help lower the chance of serious heart-related events and improve long-term blood pressure control.
- Testing a potential therapy for hypertension that is not adequately controlled
- Assessing whether treatment can reduce cardiovascular death and major heart or stroke events
- Studying care options for patients with established cardiovascular disease or elevated risk
This research reflects a strong interest in prevention, with trials aimed at improving outcomes for people living with persistent blood pressure problems and broader cardiovascular risk.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Alnylam Pharmaceuticals Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Sanixtra CZ, s.r.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| ZENITH: A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease | Alnylam Pharmaceuticals Inc. | Phase III | Recruiting | Feb 2026 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| ZILEBESIRAN | 1 | Unknown | 2026-02-09 | 2026-02-09 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.